| Treatment of hypercalcemia. | |
| | |
MedLine Citation:
|
PMID: 6337798 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The indications, effectiveness, and adverse effects of the numerous treatment modalities for hypercalcemia are presented. Results of a retrospective chart review of 72 admissions (53 patients) for hypercalcemia-related diseases are presented to emphasize the therapeutic principles that should be applied in the management of these patients. Hydration, forced diuresis, oral phosphates, and glucocorticosteroid drugs are common therapeutic approaches. Combination therapy with glucocorticosteroid drugs, oral phosphates, and forced diuresis is utilized to take advantage of multiple mechanisms of action. Outpatient therapy for hypercalcemia consists primarily of glucocorticosteroid agents and oral phosphates. Most patients are treated if the serum calcium level is greater than or equal to 12 mg/dL. An algorithm is presented to assist the clinician in selecting the most efficacious treatment plan. |
| | |
Authors:
|
G T Elliott; M W McKenzie |
Related Documents
:
|
12225898 - The new orally active immunoregulator laquinimod (abr-215062) effectively inhibits deve... 20702758 - Intravenous to oral conversion of antihypertensives: a toolkit for guideline development. 2594468 - Faecal level of urobilinogen: an indication for the risk of superinfection and of failu... 10066128 - Comparative disposition kinetics of albendazole in sheep following oral and intrarumina... 7294548 - Allopurinol hepatotoxicity. report of two cases and review of the literature. 17370068 - Hiv-1 reverse transcriptase inhibitors. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drug intelligence & clinical pharmacy Volume: 17 ISSN: 0012-6578 ISO Abbreviation: Drug Intell Clin Pharm Publication Date: 1983 Jan |
Date Detail:
|
Created Date: 1983-04-07 Completed Date: 1983-04-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0212457 Medline TA: Drug Intell Clin Pharm Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 12-22 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Calcium
/
blood Chelating Agents / therapeutic use Diuresis Diuretics / therapeutic use Female Humans Hypercalcemia / drug therapy*, etiology Indomethacin / therapeutic use Male Mineralocorticoids / therapeutic use Phosphates / therapeutic use Renal Dialysis Serum Albumin / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Chelating Agents; 0/Diuretics; 0/Mineralocorticoids; 0/Phosphates; 0/Serum Albumin; 53-86-1/Indomethacin; 7440-70-2/Calcium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA).
Next Document: Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical tr...